BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Dr. Merit Cudkowicz and Dr. Ralph Kern presentation will be featured in Oral Presentation in the Clinical Trials Platform Session
Clinical experience with outpatient NurOwn® administration will be presented in poster session
NEW YORK, Nov. 23, 20... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn, Amyotrophic lateral sclerosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news